In short
Overview
Forty is when the modifiable risks stop being theoretical and start compounding. It is also when the returns on fixing them are highest.
Direct Answer
Four things matter more after 40 than before: a calculated cardiovascular risk, blood pressure yearly, sitting time, and sleep.
Metabolic syndrome affects 37.8 per cent of adults aged 40 to 59, up from 18.5 per cent at 20 to 39. That is the shift the decade brings.
The offsetting number: about 300 minutes a week of moderate to vigorous activity eliminated the excess mortality linked to sitting more than eight hours a day.
Who This Applies To
What changes at 40
| Blood pressure | Screened yearly from 40, rather than every three to five years |
| Metabolic syndrome | Prevalence roughly doubles from the previous decade |
| Breast screening | Discussed from 40 |
| Eyes | Periodic comprehensive examination from 40, for glaucoma |
| Prostate discussion | From 40 to 45 at higher risk, otherwise from 50 |
| Coronary calcium | Becomes relevant where risk is borderline or intermediate |
Option Comparison / Decision Criteria
Regular exercise cut mortality by 27 per cent, vigorous by 32, both by 50 per cent in 252,925 adults aged 50 to 71. Framingham put the life expectancy gain at 50 at 1.3 to 3.7 years for men and 1.5 to 3.5 for women
Over eight hours a day raises mortality independently, and worse when uninterrupted. That association disappeared at about 300 minutes a week of moderate to vigorous activity
Seven hours or more for adults 18 to 60. About a third of adults get less. A large weekend to weekday gap is the clearest sign of chronic debt
Screened yearly with a countable question, and usually the highest yield item in this group
Why an In-Person Physician Review Matters
Why the risk calculation is the starting point It puts you in one of four bands, and each has a defined answer: under 3 per cent lifestyle only, 3 to 5 per cent uncertain and often settled by a calcium score, 5 to 10 per cent statin usually suggested, 10 per cent or more treat.
Between 30 and 59, if the 10 year figure is low or borderline, a 30 year estimate is added, because a low short term risk can sit alongside a high lifetime one. Where the calculator understates you LDL of 190 mg/dL or above, which needs assessment for familial hypercholesterolaemia. It affects about 1 in 300 people Type 1 or type 2 diabetes, both underestimated by most models Family history of early heart disease, which is a risk enhancer even where the model ignores it Women, whose calculated risk understates them. 36 per cent of middle aged women rated low or borderline had detectable coronary calcium What is not worth doing at 40 Whole body scans, multi cancer blood tests, biological age panels, growth hormone, IV infusions, and broad hormone screens without a question attached. None has been shown to improve outcomes and all generate findings that need chasing.
Frequently Asked Questions
Blood pressure screening becomes yearly, metabolic syndrome prevalence roughly doubles from the previous decade, breast screening and eye examinations become relevant, and a coronary calcium score starts to be useful at borderline or intermediate risk.
Sitting over eight hours a day raises mortality independently of activity, and it is worse when uninterrupted. That excess disappeared in people doing about 300 minutes a week of moderate to vigorous activity, which is roughly 45 minutes a day.
Yes. About 9 per cent of normal weight people meet the criteria, and in Framingham data they had raised diabetes and cardiovascular risk while people with obesity but without metabolic syndrome did not.
It is one of the few things that changes measurably within weeks. In a randomised trial, extending sleep by 1.2 hours a night cut energy intake by 270 kcal a day and weight by 0.87 kg in two weeks, with no diet involved.
Evidence
Where this information comes from
Every figure on this page is taken from the sources below. All of them are free to read, so you can check them yourself.
- Ageing and health
- Physical activity
- Cardiovascular diseases
- Cardiovascular disease: risk assessment and reduction
This page is general medical information and does not replace a personal consultation. Trial results are averages across large groups, not a prediction for any one person.